Rchr
J-GLOBAL ID:201901011064652386   Update date: May. 23, 2024

Ohmura Kazumasa

Ohmura Kazumasa
Research field  (1): Allergies and connective tissue disease
Research theme for competitive and other funds  (4):
  • 2022 - 2025 An exploratory study of extracellular mitochondrial proteins as novel markers of insulin resistance.
  • 2019 - 2022 An exploratory study of extracellular proteins as novel markers of organ-specific glucose dysmetabolism.
  • 2018 - 2021 直接経口抗凝固薬療法時における出血および血栓リスクの指標作成に関する研究
  • 2016 - 2019 Novel murine model of recurrent miscarriages
Papers (36):
  • Nobuhiko Takahashi, Atsushi P. Kimura, Takayuki Yoshizaki, Kazumasa Ohmura. Imeglimin modulates mitochondria biology and facilitates mitokine secretion in 3 T3-L1 adipocytes. Life Sciences. 2024. 122735-122735
  • Masahiro Ieko, Kazumasa Ohmura, Sumiyoshi Naito, Mika Yoshida, Hisaomi Sasaki, Tsuyoshi Sato, Norifumi Sugawara, Nobuhiko Takahashi, Akitada Ichinose. Considerations for simultaneous detection of autoantibodies to coagulation factor and lupus anticoagulant. Exploration of Immunology. 2023. 286-299
  • Masahiro Ieko, Sumiyoshi Naito, Mika Yoshida, Kazumasa Ohmura, Nobuhiko Takahashi, Norifumi Sugawara, Kazuki Kiyohara, Kenji Shimosegawa, Akitada Ichinose. Lupus anticoagulant-hypoproaccelerin (factor V) syndrome (LAHPS-V): a new hemorrhagic condition associated with lupus anticoagulant. International Journal of Hematology. 2022. 116. 1. 152-154
  • Masahiro Ieko, Kazumasa Ohmura, Sumiyoshi Naito, Mika Yoshida, Makoto Saito, Kazuki Kiyohara, Shinri Miyazima, Takahiro Maeta, Akihiro Ohtsu, Kenji Shimosegawa, et al. Measurement of coagulation factor antibody levels is useful for diagnosis and determining therapeutic efficacy in hemorrhagic patients with autoantibodies to coagulation factor VIII and factor V: results from a single center in Japan. International Journal of Hematology. 2021. 115. 1. 11-20
  • Osamu Kumano, Masahiro Ieko, Yutaka Komiyama, Sumiyoshi Naito, Mika Yoshida, Nobuhiko Takahashi, Kazumasa Ohmura, Mineji Hayakawa. Characterization of fibrin/fibrinogen degradation products reagents and their utility in critical care patients with enhanced fibrinolysis. International Journal of Laboratory Hematology. 2021. 43. 4. 813-820
more...
MISC (91):
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page